Magali Barbieri

Magali Barbieri

Auto-generated profile, based on publicly available information

Magali Barbieri

Institut national d'études démographiques, 9 cours des Humanités, CS 50004, 93322, Aubervilliers, Cedex, France.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Science Advances
Verified
Journal Article
Open access
EWElizabeth Wrigley-Field
Elizabeth Wrigley-Field
MKMathew V. Kiang
Mathew V. Kiang
ARAlicia R. Riley
Alicia R. Riley
MBMagali Barbieri
Magali Barbieri
YCYea-Hung Chen
Yea-Hung Chen
JLJonathon Leider
Jonathon Leider
Age-based COVID-19 vaccination prioritizes white people above higher-risk others; geographic prioritization improves equity.

10 December 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CTCatalina Torres
Catalina Torres
JGJenny García
Jenny García
FMFrance Meslé
France Meslé
MBMagali Barbieri
Magali Barbieri
FBFlorian Bonnet
Florian Bonnet
JRJean-Marie Robine
Jean-Marie Robine
The COVID-19 pandemic is characterized by successive waves that each developed differently over time and through space. We aim to provide an in-depth analysis of the evolution of COVID-19 mortality during 2020 and 2021 in a selection of countries. We focus on five European countries and the United States. Using standardized and age-specific mortality rates, we address variations in COVID-19 mortality within and between countries, and demographic characteristics and seasonality patterns. Our results highlight periods of acceleration and deceleration in the pace of COVID-19 mortality, with substantial differences across countries. Periods of stabilization were identified during summer (especially in 2020) among the European countries analyzed but not in the United States. The latter stands out as the study population with the highest COVID-19 mortality at young ages. In general, COVID-19 mortality is highest at old ages, particularly during winter. Compared with women, men have higher COVID-19 mortality rates at most ages and in most seasons. There is seasonality in COVID-19 mortality for both sexes at all ages, characterized by higher rates during winter. In 2021, the highest COVID-19 mortality rates continued to be observed at ages 75+, despite vaccinations having targeted those ages specifically.

26 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
EWElizabeth Wrigley-Field
Elizabeth Wrigley-Field
MKMathew V Kiang
Mathew V Kiang
ARAlicia R Riley
Alicia R Riley
MBMagali Barbieri
Magali Barbieri
YCYea-Hung Chen
Yea-Hung Chen
JLJonathon Leider
Jonathon Leider
COVID-19 mortality increases dramatically with age and is also substantially higher among Black, Indigenous, and People of Color (BIPOC) populations in the United States. These two facts introduce tradeoffs because BIPOC populations are younger than white populations. In analyses of California and Minnesota--demographically divergent states--we show that COVID vaccination schedules based solely on age benefit the older white populations at the expense of younger BIPOC populations with higher risk of death from COVID-19. We find that strategies that prioritize high-risk geographic areas for vaccination at all ages better target mortality risk than age-based strategies alone, although they do not always perform as well as direct prioritization of high-risk racial/ethnic groups. One-sentence summary: Age-based COVID-19 vaccination prioritizes white people above higher-risk others; geographic prioritization improves equity.

1 October 2019 in Population & Sociétés
Verified
Journal Article
Open access
PDF file
MBMagali Barbieri
Magali Barbieri
Aux États-Unis, l’espérance de vie à la naissance a cessé d’augmenter à partir de 2010 et elle a même diminué chez les hommes depuis 2014. Le décrochement des États-Unis par rapport aux autres pays de l’OCDE a commencé vers 1980 et il s’est aggravé. Les progrès dans la lutte contre les maladies cardiovasculaires, en grande partie responsables de la hausse de l’espérance de vie au cours des années 1970 et 1980, ont ralenti depuis 2000 en lien notamment avec la croissance de l’obésité et du diabète. L’épidémie d’overdoses de drogues explique la moitié des années de vie perdues entre 2014 et 2017. La mortalité due à cette cause a été multipliée par plus de cinq entre 1980 et 2017.

22 February 2022 in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
Verified
Journal Article
Closed access
MBMagali Barbieri
Magali Barbieri
Objectives: The articles examines the contribution of internal socioeconomic disparities in mortality to the U.S. international disadvantage in life expectancy at birth. Methods: Using individual death records from the U.S. national vital statistics system for years 1982–2019 and data for other countries from the Human Mortality Database, we compare age-specific death rates and life expectancy between counties classified into 10 socioeconomic categories and 20 high-income countries. We also calculate the number of years of life lost in each socioeconomic decile in relation to the comparison set. Results: There is a clear and increasing socioeconomic gradient of mortality in the United States, but the growing divergence in internal mortality trends does not explain the rising gap between the country and its peers. In 2019, even American women in the most socioeconomically advantaged decile lived shorter lives, while only 10% of men in the most affluent decile fared better than their peers. The long-standing U.S. disadvantage in young adult mortality has been growing and the country’s previous advantage in mortality at ages 75 years and older has virtually disappeared for all but for Americans in the most affluent counties. Discussion: The similar age pattern of differences in mortality rates between each socioeconomic deciles and the comparison group suggests that the underlying factors might be the same. The role of external causes (including drug overdoses) for middle-aged adults and a slowing down in progress to control cardiovascular diseases at older ages at the national level are consistent with this pattern.

10 January 2025 in Demographic Research
Verified
Journal Article
Open access
PDF file
ADAmeer Dharamshi
Ameer Dharamshi
MAMonica Alexander
Monica Alexander
CWCeleste Winant
Celeste Winant
MBMagali Barbieri
Magali Barbieri
Volume 52 - Article 3 | Pages 71–110